Brand check

Is Piriton banned in India?

Last checked 1 October 2026

Piriton. Status: SC interim relief · on sale.

Piriton expectorant is on sale in India as of 1 Oct 2026 under Supreme Court interim relief granted in February 2019 against its 7 Sep 2018 ban (S.O. 4532(E)); plain Piriton tablets were never banned.

Classification
Ban stayed by a court
Decided by
CDSCO / Ministry of Health and Family Welfare; Supreme Court of India
Reference
S.O. 4532(E), 7 Sep 2018; Supreme Court order of 14 Feb 2019 (pre-1988 FDC, under expert examination)
Evidence
Government document
Latest action
14 February 2019
Last checked
1 October 2026

Photo: Cocillana.JPG by unknown (CC0). All photo credits.

Primary government sourceTier 1: government primary source

List of drugs prohibited for manufacture and sale through gazette notifications under section 26A (as on 22.11.2021)

CDSCO / Ministry of Health and Family Welfare; Supreme Court of India · S.O. 4532(E), 7 Sep 2018; Supreme Court order of 14 Feb 2019 (pre-1988 FDC, under expert examination) · 22 November 2021

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Governing authority
CDSCO, MoHFW; Supreme Court of India
Ban notification
S.O. 4532(E), 7 Sep 2018 (328-FDC wave)
Court relief
Supreme Court, 14 Feb 2019, with Saridon and Dart (pre-1988 FDCs under examination)
Plain Piriton tablets
Chlorpheniramine alone, never banned
Marketer
GSK / Haleon

Piriton is two products. Piriton tablets are plain chlorpheniramine maleate, an old antihistamine, and have never been banned. Piriton expectorant is a cough syrup that combines chlorpheniramine with ammonium chloride and sodium citrate, and that is the product with a legal history.

The expectorant was among the 328 fixed-dose combinations prohibited on 7 September 2018 under S.O. 4532(E), after the Drugs Technical Advisory Board reviewed the list returned by the Supreme Court. GSK challenged the notification. In February 2019 a Supreme Court bench of Justices Nariman and Malhotra granted interim relief to Piriton expectorant, Saridon and Dart, allowing them to be sold until the petitions are decided. That interim order is still the operative position, and the final hearing has not been reported.

One distinction matters. The June 2023 notification that banned 14 older FDCs included a chlorpheniramine, ammonium chloride, sodium citrate and menthol syrup (S.O. 2406(E)). That is a different formulation from Piriton expectorant, which contains no menthol; Piriton's own entry on CDSCO's list, S.O. 4532(E), is still marked as under examination following the Supreme Court order.

For families, the practical points are ordinary: Piriton tablets cause drowsiness, and no cough syrup, including the expectorant, should be given to a child under two after the DGHS advisory of October 2025.

What this means for you

Both forms are available

Piriton tablets were never affected; the expectorant is on sale under the court order.

The expectorant's status could change

If the Supreme Court decides against it, the 2018 ban would revive.

Children under two

The October 2025 DGHS advisory against cough syrups for under-2s applies to the expectorant.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Batches flagged in CDSCO alerts

No NSQ batch on record. No product matching this name appears in CDSCO or state-lab NSQ alerts from Jan 2019 to September 2026. Absence from the alerts is not proof of quality, check your batch number.

Sources

Government documents

News reports